Core Insights - Tilray Brands, Inc. is expected to report a quarterly loss of 20 cents per share for Q2 2025, compared to a loss of 3 cents per share in the same quarter last year [1] - The consensus estimate for Tilray Brands' quarterly revenue is $210.95 million, which remains unchanged from the previous year [1] - Following President Trump's executive order to expedite the rescheduling of marijuana to a Schedule III substance, Tilray's shares fell by 2.5% to close at $9.26 [2] Analyst Ratings - Analyst Pablo Zuanic from Zelman & Assoc maintained a Neutral rating on Tilray Brands as of July 29, 2025, with an accuracy rate of 52% [4] - Analyst Michael Lavery from Piper Sandler also maintained a Neutral rating but reduced the price target from $2 to $1 on April 9, 2025, with an accuracy rate of 63% [4]

Core Insights - Jeremy Szafron has joined Kitco News as an anchor and producer, bringing a wealth of experience in journalism, particularly in finance and current affairs [1][5] Group 1: Career Background - Jeremy began his journalism career in 2006 at CTV, initially focusing on entertainment before transitioning to business reporting, particularly in mining and small-cap sectors [2] - He gained recognition for his macro-financial and market trends analysis, becoming a sought-after commentator on CTV Morning Live and CTV News Network [2] - A significant highlight of his career was covering the 2010 Vancouver Olympic Games, which led to the development of an online video news program for PressReader, a digital newsstand with 8,000 editions in 60 languages [3] Group 2: Digital Media Ventures - In 2012, Jeremy launched The Green Scene Podcast, which quickly attracted over 400,000 subscribers and positioned him as a prominent voice in the cannabis industry [4] - Following this success, he established Investor Scene and Initiate Research, platforms that provide exclusive market insights and deal-flow opportunities in mining and Canadian small-cap markets [4] Group 3: Professional Expertise - Jeremy has served as a market strategist and investor relations consultant for various publicly traded companies across mining, energy, consumer packaged goods (CPG), and technology sectors [5] - He holds a BA in Journalism from Concordia University, which has supported his diverse career trajectory [5]

Core Insights - Tilray Brands, Inc. (TLRY) is set to report its second-quarter fiscal 2026 results on January 8, 2026, with revenue expectations of $209.7 million, reflecting a 0.6% decline year-over-year, and a consensus loss estimate of 14 cents per share, an improvement from a loss of $1 in the same quarter last year [1][2] Financial Performance - The company achieved a 100% earnings surprise in the last reported quarter but has an average negative earnings surprise of 8.3% over the trailing four quarters [2] Key Factors Impacting Performance - The upcoming quarterly performance may reveal weaknesses, including margin pressures in core segments due to a higher mix of lower-margin cannabis products and ongoing challenges in the beverage business [3][9] - The beverage segment is experiencing softness due to SKU rationalization, but the company is focused on turnaround strategies, including beer integration and Project 420 [4][9] - Strength in the Wellness business, supported by a robust product portfolio and expansion efforts, is expected to provide some cushion to the overall performance [5][9] Earnings Prediction Model - The current model does not predict an earnings beat for Tilray Brands, as it has an Earnings ESP of 0.00% and a Zacks Rank of 3, indicating a neutral outlook [6]

Industry Overview - The cannabis industry is evolving with renewed optimism as investors look toward 2026, with Canadian companies at the forefront of global expansion due to strong medical programs and increasing international demand [1][2] - Investors face challenges such as volatility, regulation, and changing consumer trends [1] Company Summaries Tilray Brands Inc. (TLRY) - Tilray is one of the largest cannabis and consumer wellness companies in Canada, operating in Canada, Europe, Latin America, and emerging medical markets [2] - The company does not own U.S. cannabis dispensaries but partners with licensed distributors, allowing for brand expansion while remaining compliant [2] - Recent financial performance shows gradual improvement, with revenue growth from both cannabis and beverage operations, although profitability remains challenging due to operating expenses and restructuring costs [4] - Investors are optimistic about potential catalysts such as expanding international medical programs and regulatory changes, but the stock may experience price swings [4] Cronos Group Inc. (CRON) - Cronos is a global cannabis and cannabinoid company focused on developing branded products for adult-use and medical markets, emphasizing quality and innovation [6] - The company collaborates with licensed partners instead of owning U.S. dispensaries, allowing for cautious growth while remaining compliant [6] - Financially, Cronos has reported steady revenue growth supported by strong demand for premium products, maintaining a solid balance sheet and improving gross margins [8] - Despite periodic net losses, the company's disciplined approach to growth appeals to investors seeking stability [8] Aurora Cannabis Inc. (ACB) - Aurora is a recognized cannabis producer in Canada, heavily involved in medical cannabis across multiple regulated markets [9] - The company focuses on export partnerships and compliant product channels instead of operating U.S. dispensaries [9] - Aurora's financial performance reflects a strategic shift toward profitability, with improved gross margins and reduced operating expenses [11] - The company has achieved positive adjusted earnings recently, indicating operational progress, and is expected to continue growth in international medical markets [11]

Core Insights - Tilray Brands, Inc. is redefining mindful drinking with a new collection that includes hemp-derived delta-9 THC cocktails, zero-proof spirits, and non-alcoholic beers, aiming to make moderation feel indulgent rather than limiting [1][4] - The sober curious movement is driving consumer demand for flavorful and sophisticated drinks, and Tilray's Dry January lineup is positioned to meet this demand with innovative offerings [2][4] Company Overview - Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with operations in multiple regions including Canada, the United States, Europe, Australia, and Latin America, focusing on cannabis, beverage, wellness, and entertainment [5] - The company supports over 40 brands in more than 20 countries, offering a diverse range of products including cannabis offerings, hemp-based foods, and craft beverages [5] Market Trends - Non-alcoholic beer sales increased by over 20% last year, indicating a growing trend towards mindful drinking, with THC-infused beverages also gaining popularity as functional alternatives [4] - The Dry January initiative is not just a seasonal trend but reflects a broader shift in consumer preferences towards healthier drinking options [4] Product Offerings - The Dry January Collection includes: - Happy Flower: Sparkling THC cocktails infused with hemp-derived Delta-9 THC [8] - Fizzy Jane's: THC seltzers with refreshing flavors [8] - Mock One: Premium zero-proof spirits designed to replicate traditional spirits [8] - Runner's High: Non-alcoholic beer for active lifestyles [8] - Montauk Brewing: Non-alcoholic craft brews including N.A IPA and N.A. Golden [8] - 10 Barrel Brewing: NA Apocalypse IPA, a non-alcoholic version of their original IPA [8]

分组1 - The cannabis sector has experienced significant declines, with Curaleaf's stock down over 66% all-time, reflecting a broader collapse in the industry over the past five years [5][6][8] - Recent changes in U.S. policy, particularly the Trump administration's indication of reclassifying marijuana as a less-dangerous drug, may open avenues for medical research and potentially lead to future legalization [7] - The iShares Bitcoin Trust ETF has also seen a decline of nearly 30% from its late-2025 peak, indicating volatility in the cryptocurrency market [8] 分组2 - Lululemon's stock lost more than 40% in 2025, attributed to weaknesses in the retail sector and concerns regarding leadership [8]

Industry Overview - The cannabis industry is poised for significant growth in 2026, especially with the recent reclassification of cannabis from Schedule 1 to Class 3, which could facilitate import and export opportunities [2][3] - The changing legal landscape in the U.S. and other regions is expected to boost investor confidence and create a more robust market for cannabis operators globally [3] Company Highlights - **Green Thumb Industries Inc. (OTC:GTBIF)** reported Q3 2025 earnings with a revenue of $291.4 million, reflecting a 1.6% increase year-over-year. The company had cash on hand of $226.2 million and a GAAP net income of $23.3 million, translating to $0.10 per share. Adjusted EBITDA was $80.2 million, representing 27.5% of revenue [10] - **Jushi Holdings Inc. (OTC:JUSHF)** is a vertically integrated cannabis company involved in cultivation, processing, retail, and distribution for medical and adult-use markets. The company recently amended the CEO's employment agreement, which was approved by independent directors [11][12] - **Greenlane Holdings, Inc. (OTC:GNLN)** focuses on the development and distribution of cannabis accessories and vape devices. In its Q3 2025 update, the company reported total revenue of $0.74 million, with operating expenses of $4.0 million and a net loss of $8.9 million [12][13] Investment Opportunities - The article suggests that investors should keep an eye on several marijuana stocks for potential gains in 2026, including Green Thumb Industries, Jushi Holdings, and Greenlane Holdings [4][9]

Core Viewpoint - Simply Solventless Concentrates Ltd. (SSC) has appointed Charles Vennat to its board of directors, enhancing its leadership with significant experience in the cannabis and consumer packaged goods sectors [1][3]. Group 1: Appointment Details - Charles Vennat is an accomplished CEO with a background in leading complex manufacturing and regulated cannabis businesses [1][2]. - He has previously held senior leadership roles at 48North, Greentone Enterprises, and Bastos of Canada, providing him with deep expertise in the cannabis industry [2]. - Concurrent with his appointment, SSC granted Vennat 500,000 stock options at an exercise price of $0.15, with a vesting schedule over three years [3]. Group 2: Company Overview - Simply Solventless Concentrates Ltd. is a public company incorporated under the Business Corporations Act (Alberta) [4]. - The company's mission is to provide pure, potent, terpene-rich ready-to-consume cannabis products to discerning consumers [4].

Core Insights - Tilray Brands, Inc. is promoting cannabis-infused beverages as a mindful alternative during Dry January, emphasizing flavor and cannabinoid consistency [1][2] - The non-alcoholic beverage market in Canada has seen a significant growth of 24% year-over-year, reaching a total of $199 million, indicating a rising consumer preference for alcohol-free options [2] Product Offerings - Mollo and XMG are the two main brands under Tilray's campaign, offering a variety of cannabis-infused beverages that cater to different tastes and occasions [1][2] - Mollo Seltzer includes flavors like Blackberry, Wild Berry Açaí, Lemon, Mango, and Watermelon Lime, each containing 10 mg THC and 20 mg CBG per can [6][15] - XMG offers products such as Cream Soda Zero, Grape Ape Soda, and Tropical Cream Float, featuring 10 mg THC and varying CBG content, with some options being sugar-free [10][11][16] Market Positioning - The campaign positions cannabis beverages as a leading innovation within the non-alcoholic movement, appealing to adults looking for flavorful and mindful drinking options [2] - Tilray aims to elevate consumer experiences through its diverse product range, which includes over 40 brands across more than 20 countries, focusing on wellness and lifestyle [18]

Group 1 - The 420 Investor service, focused on cannabis stocks, was launched in 2013 and has now moved to Seeking Alpha, continuing to provide extensive coverage of the sector [1] - Alan Brochstein, a prominent figure in cannabis investment, has been involved in the financial industry since 1986 and founded AB Analytical Services in 2007 to offer independent consulting [1] - The 420 Investor group covers 20 cannabis stocks, providing investment news, earnings report previews, and post-report analyses, along with a model portfolio and multiple weekly video analyses [1]